Lang CC - Search Results

1

Genetic Risk of Diverticular Disease Predicts Early Stoppage of Nicorandil.

Noyes JD, Mordi IR, Doney AS, Palmer CNA, Pearson ER, Lang CC. Noyes JD, et al. Among authors: lang cc. Clin Pharmacol Ther. 2020 Dec;108(6):1171-1175. doi: 10.1002/cpt.1941. Epub 2020 Jul 10. Clin Pharmacol Ther. 2020. PMID: 32535905

2

Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.

Donnelly LA, Palmer CN, Whitley AL, Lang CC, Doney AS, Morris AD, Donnan PT. Donnelly LA, et al. Among authors: lang cc. Pharmacogenet Genomics. 2008 Apr;18(4):279-87. doi: 10.1097/FPC.0b013e3282f60aad. Pharmacogenet Genomics. 2008. PMID: 18334912

3

A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.

Donnelly LA, Doney AS, Dannfald J, Whitley AL, Lang CC, Morris AD, Donnan PT, Palmer CN. Donnelly LA, et al. Among authors: lang cc. Pharmacogenet Genomics. 2008 Dec;18(12):1021-6. doi: 10.1097/FPC.0b013e3283106071. Pharmacogenet Genomics. 2008. PMID: 18815589

4

Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure.

AlZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, Petrie JR, Struthers AD, Lang CC. AlZadjali MA, et al. Among authors: lang cc. J Am Coll Cardiol. 2009 Mar 3;53(9):747-53. doi: 10.1016/j.jacc.2008.08.081. J Am Coll Cardiol. 2009. PMID: 19245964 Free article.

5

Compliance to recommended liver function monitoring in patients on statin therapy.

Leaver H, Keng Lim T, Thomson P, Leaver J, Choy AM, Lang CC. Leaver H, et al. Among authors: lang cc. Cardiovasc Ther. 2009 Summer;27(2):96-100. doi: 10.1111/j.1755-5922.2009.00082.x. Cardiovasc Ther. 2009. PMID: 19426246 Free article.

6

Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.

Zhou K, Donnelly L, Burch L, Tavendale R, Doney AS, Leese G, Hattersley AT, McCarthy MI, Morris AD, Lang CC, Palmer CN, Pearson ER. Zhou K, et al. Among authors: lang cc. Clin Pharmacol Ther. 2010 Jan;87(1):52-6. doi: 10.1038/clpt.2009.176. Epub 2009 Sep 30. Clin Pharmacol Ther. 2010. PMID: 19794412

7

Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.

George J, Doney A, Palmer CN, Lang CC. George J, et al. Among authors: lang cc. Cardiovasc Ther. 2010 Jun;28(3):135-8. doi: 10.1111/j.1755-5922.2010.00176.x. Cardiovasc Ther. 2010. PMID: 20557312 Free article. No abstract available.

8

Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.

Donnelly LA, Doney AS, Tavendale R, Lang CC, Pearson ER, Colhoun HM, McCarthy MI, Hattersley AT, Morris AD, Palmer CN. Donnelly LA, et al. Among authors: lang cc. Clin Pharmacol Ther. 2011 Feb;89(2):210-6. doi: 10.1038/clpt.2010.255. Epub 2010 Dec 22. Clin Pharmacol Ther. 2011. PMID: 21178985 Free PMC article.

9

State of play of pharmacogenetics and personalized medicine in heart failure.

Parry HM, Doney AS, Palmer CN, Lang CC. Parry HM, et al. Among authors: lang cc. Cardiovasc Ther. 2013 Dec;31(6):315-22. doi: 10.1111/1755-5922.12030. Cardiovasc Ther. 2013. PMID: 23480579 Free article. Review.

10

Renin-angiotensin-aldosterone system inhibitors in heart failure.

Shearer F, Lang CC, Struthers AD. Shearer F, et al. Among authors: lang cc. Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12. Clin Pharmacol Ther. 2013. PMID: 23852393 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters